Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
A practical method for assessing quantitative scanner accuracy with long-lived radionuclides: The ARTnet insert.
Bailey DL, Willowson KP, Muñoz-Ferrada C. Bailey DL, et al. Asia Ocean J Nucl Med Biol. 2024;12(1):27-34. doi: 10.22038/AOJNMB.2023.71860.1503. Asia Ocean J Nucl Med Biol. 2024. PMID: 38164228 Free PMC article.
Furthermore, it uses less radioactivity in a smaller volume than would be required to fill the entire phantom as is usually done. Long-term storage is practical while allowing radioactive decay of the insert contents....
Furthermore, it uses less radioactivity in a smaller volume than would be required to fill the entire phantom as is usually done. Long-te …
Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.
Gordon S, Chan DLH, Bernard EJ, Eslick ME, Willowson KP, Roach PJ, Engel AF, Maher R, Clarke SJ, Agarwal V, Yasmin L, De Silva M, Mascall S, Conner A, Nevell D, Pavlakis N, Bailey DL. Gordon S, et al. Among authors: bailey dl. J Cancer Res Clin Oncol. 2023 Aug;149(10):7717-7728. doi: 10.1007/s00432-023-04706-1. Epub 2023 Apr 1. J Cancer Res Clin Oncol. 2023. PMID: 37004598 Free PMC article.
Median overall survival (OS) from first receiving LUTATE was 72.5 months with a median progression-free survival (PFS) of 32.3 months. No evidence of renal toxicity was seen. The major long-term complication seen was myelodysplastic syndrome (MDS) with a 5% incidence. ...
Median overall survival (OS) from first receiving LUTATE was 72.5 months with a median progression-free survival (PFS) of 32.3 months. No ev …
Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry.
Marquis H, Deidda D, Gillman A, Willowson KP, Gholami Y, Hioki T, Eslick E, Thielemans K, Bailey DL. Marquis H, et al. Among authors: bailey dl. EJNMMI Phys. 2021 Feb 17;8(1):16. doi: 10.1186/s40658-021-00362-x. EJNMMI Phys. 2021. PMID: 33598750 Free PMC article.
We propose a novel approach to SPECT reconstruction in a theranostic setting, which we term SPECTRE (single photon emission computed theranostic reconstruction); using a diagnostic PET image, with its superior resolution, to guide the SPECT reconstruction of the therapeuti …
We propose a novel approach to SPECT reconstruction in a theranostic setting, which we term SPECTRE (single photon emission computed …
Defining adherence to therapeutic exercise for musculoskeletal pain: a systematic review.
Bailey DL, Holden MA, Foster NE, Quicke JG, Haywood KL, Bishop A. Bailey DL, et al. Br J Sports Med. 2020 Mar;54(6):326-331. doi: 10.1136/bjsports-2017-098742. Epub 2018 Jun 6. Br J Sports Med. 2020. PMID: 29875278
OBJECTIVE: To establish the meaning of the term 'adherence' (including conceptual and measurement definitions) in the context of therapeutic exercise (TE) for musculoskeletal (MSK) pain. ...
OBJECTIVE: To establish the meaning of the term 'adherence' (including conceptual and measurement definitions) in the context of ther …
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Hofman MS, Murphy DG, Williams SG, Nzenza T, Herschtal A, Lourenco RA, Bailey DL, Budd R, Hicks RJ, Francis RJ, Lawrentschuk N. Hofman MS, et al. Among authors: bailey dl. BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3. BJU Int. 2018. PMID: 29726071 Clinical Trial.
Secondary objectives include comparing management impact, the number of equivocal studies, the incremental value of second-line imaging in patients who cross over, the cost of each imaging strategy, radiation exposure, inter-observer agreement and safety of PSMA-PET/CT. Longer- …
Secondary objectives include comparing management impact, the number of equivocal studies, the incremental value of second-line imaging in p …